Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating sequential AG regimen (nab-paclitaxel + gemcitabine) followed by modified FOLFIRINOX as neoadjuvant chemotherapy fo…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas [Phase 1]
Phase 1 trial assessing whether Onivyde manufactured at two production sites is equivalent in safety and pharmacokinetics for adults with me…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer [Phase 2]
Clinical trial update on a Phase 2 study evaluating nab-paclitaxel and gemcitabine with or without VCN-01 in metastatic pancreatic cancer; t…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer [Phase 3]
A Phase 3 multi-center trial evaluating multiple regimens for metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation [Phase 1]
Phase 1 study of MRTX1133 in KRAS G12D-mutant solid tumors has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors
The INTER-Regional COHORTE study of long-term pancreatic cancer survivors has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: tailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancEr [Phase 2]
Phase 2 trial evaluating tailored decitabine repurposing for KRAS-dependent refractory pancreatic cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors [Phase 2]
Phase 2 study evaluating the efficacy of tislelizumab and spartalizumab across multiple cancers with PD-1 high mRNA expression; the trial is…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency [Phase 2]
Phase 2 trial evaluating Pancreaze (pancrelipase) in patients with pancreatic adenocarcinoma and exocrine pancreatic insufficiency; results …
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma [Phase 1]
Phase 1b study of CCX872-B in pancreatic adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma [Phase 2]
A Phase 2 trial evaluating carbon ion radiotherapy for resectable or borderline resectable pancreatic cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating disulfiram in combination with chemotherapy for patients with refractory solid tumors or metastatic pancreatic canc…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Evaluation of Polychemotherapy With XELOXIRI-3 in Elderly or Frail Patients With Advanced Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating XELOXIRI-3 in elderly or frail patients with advanced pancreatic adenocarcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of an immunostimulatory oncolytic adenovirus has completed with posted results across pancreatic adenocarcinoma, ovarian c…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas [Phase 2]
Phase 2 trial of ganitumab in locally advanced unresectable pancreatic cancer has been terminated; results were posted on 2024-11-08.
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery [Phase 3]
Phase 3 trial updates evaluate gemcitabine with or without erlotinib followed by the same regimen with or without radiation therapy and cape…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Study of Proton Therapy in Adjuvant Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating proton therapy as adjuvant treatment after surgical resection for pancreatic adenocarcinoma has complete…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas [EARLY_Phase 1]
An early-phase pilot study at Johns Hopkins evaluated a combination of CY (cyclophosphamide), pembrolizumab, GVAX pancreatic cancer vaccine,…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors [Phase 1, Phase 2]
Phase I/II study of OBI-3424 in advanced solid tumors, including pancreatic adenocarcinoma, has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: STR + Anti PD-1 Therapy in Patients with Locally Advanced Unresectable Pancreatic Adenocarcinoma [Phase 1, Phase 2]
The document reports completion of a Phase 1/2 trial evaluating STR plus an anti-PD-1 therapy in patients with locally advanced unresectable…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 trial evaluating liposomal irinotecan in combination with 5-FU and oxaliplatin as preoperative therapy for pancreatic adenocarcino…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients [Phase 2]
Phase 2 study evaluating the safety and efficacy of combining BL-8040 (motixafortide) with pembrolizumab in metastatic pancreatic adenocarci…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas [Phase 2]
Phase 2 trial evaluating GVAX pancreatic tumor cell vaccine with cyclophosphamide, SBRT, and the FOLFIRINOX regimen in patients with resecte…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma
A completed clinical trial update examining whether albumin levels, HALP score, and LCR value can predict survival and recurrence in pancrea…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors [Phase 2]
A Phase 2 trial evaluating Cediranib in combination with Olaparib in advanced solid tumors has posted results as of 2024-07-30. Indications …